Back to results
US 2016/0250194 A1Published application
Methods of Making and Using Thioxothiazolidine and Rhodanine Derivatives as HIV-1 and JSP-1 Inhibitors
AssigneesSouthern Methodist University, The Johns Hopkins University
InventorsEdward R. Biehl, Sukanta Kamila, Ted M. Dawson
Life of this patent
Estimating the term…
Abstract
The present invention provides methods of making and using 5-(2-(indol-3-yl)-2-oxoethylidene)-3-phenyl-2-thioxothiazolidin-4-one derivatives having HIV-1 or JSP-1 inhibitory activity.
Claims16
A method of reducing the activity of one or more enzymes comprising the steps of:
- contacting the one or more enzymes with a thioxothiazolidin compound having a 5-(2-(indol-3-yl)-2-oxoethylidene)-3-phenyl-2-thioxothiazolidin-4-one skeleton to reduce the activity of the one or more enzymes, wherein the one or more enzymes are HIV-1 or JNK-stimulating phosphatase-1 (JSP-1) enzymes or both.
A method of treating a subject having an enzyme disorder comprising the steps of:
- providing a subject having an enzyme disorder;
- wherein the enzyme disorder is an increase in an enzyme activity of an enzyme selected from a HIV-1 enzyme, a JNK-stimulating phosphatase-1 (JSP-1) enzymes or both;
- contacting the enzyme with a thioxothiazolidin compound having a 5-(2-(indol-3-yl)-2-oxoethylidene)-3-phenyl-2-thioxothiazolidin-4-one skeleton to reduce the enzyme activity.
Dependencies are inferred from the claim text.